Table 1.
Variable | Group 1 (n = 10) | Group 2 (n = 10) | Group 3 (n = 10) | Group 4 (n = 10) | p-value |
---|---|---|---|---|---|
Day 0 | |||||
IVS thickness (mm) | 1.27 ± 0.21 | 1.28 ± 0.15 | 1.29 ± 0.19 | 1.24 ± 0.17 | 0.526 |
PW thickness (mm) | 1.19 ± 0.23 | 1.22 ± 0.22 | 1.19 ± 0.25 | 1.21 ± 0.28 | 0.758 |
LVEDD (mm) | 7.05 ± 0.82 | 7.01 ± 0.24 | 7.01 ± 0.61 | 7.02 ± 0.92 | 0.822 |
LVESD (mm) | 3.84 ± 0.75 | 3.85 ± 0.25 | 3.75 ± 0.94 | 3.76 ± 0.67 | 0.558 |
LVEDV (µL) | 335.60 ± 73.90 | 325.80 ± 90.10 | 323.70 ± 72.10 | 329.30 ± 87.40 | 0.810 |
LVESV (µL) | 90.40 ± 15.40 | 91.20 ± 10.70 | 87.30 ± 19.50 | 89.30 ± 14.30 | 0.664 |
LVFS (%) | 47.92 ± 2.77 | 46.69 ± 2.43 | 46.24 ± 3.33 | 48.69 ± 3.19 | 0.436 |
LVEF (%) | 73.52 ± 3.30 | 72.81 ± 2.70 | 72.36 ± 2.30 | 74.78 ± 3.50 | 0.526 |
By day 60 after TAC | |||||
IVS thickness (mm) | 1.34 ± 0.05a | 2.08 ± 0.26b | 1.29 ± 0.19 | 1.87 ± 0.14b,c | < 0.001 |
PW thickness (mm) | 1.20 ± 0.51a | 1.57 ± 0.99b | 1.19 ± 0.25 | 1.41 ± 0.24b,c | < 0.001 |
LVEDD (mm) | 7.08 ± 0.12a | 7.37 ± 0.74b | 7.01 ± 0.61 | 7.23 ± 0.46c | < 0.001 |
LVESD (mm) | 3.95 ± 0.11a | 4.37 ± 0.15b | 3.75 ± 0.94 | 4.24 ± 0.24b | < 0.001 |
LVEDV (µL) | 337.20 ± 33.50a | 396.50 ± 21.10b | 323.70 ± 72.10 | 379.40 ± 81.10c | < 0.001 |
LVESV (µL) | 97.00 ± 13.20a | 150.10 ± 21.30b | 87.30 ± 19.50 | 136.60 ± 40.30b | < 0.001 |
LVFS (%) | 47.91 ± 1.27a | 40.95 ± 2.76b | 46.24 ± 3.33 | 41.46 ± 1.02b | < 0.001 |
LVEF (%) | 72.22 ± 0.90a | 62.91 ± 2.30b | 72.36 ± 2.30 | 65.25 ± 1.10d | < 0.001 |
Data are expressed as mean ± SD or %. Group 1 = DPP-4D; Group 2 = DPP-4D + TAC; Group 3 = DPP-4D + TAC + Extendin-4; Group 4 = DPP-4D + TAC + Extendin-4 + EX39-9. Dipeptidyl peptidase-IV deficiency = DPP-4D; LVEDD = left ventricular end-diastolic dimension; LVESD = left ventricular end-systolic dimension; LVEDV = left ventricular end-diastolic volume; LVESV = left ventricular end-systolic volume; LVFS = left ventricular fractional shortening; LVEF = left ventricular ejection fraction. All statistical analyses using one-way ANOVA, followed by Bonferroni multiple comparison post hoc test.
indicates significance (at 0.05 level);
indicates significance (at 0.05 level);
indicates significance (at 0.05 level);
indicates significance (at 0.05 level).